Avoid common mistakes on your manuscript.
1 Correction to: Drugs & Aging https://doi.org/10.1007/s40266-018-0567-x
In Sect. 4.3 “Factors Associated with Statin Use in the Oldest Old”, the second paragraph contains errors that affect the interpretation of the studies discussed with respect to the effect of co-morbidities.
The paragraph currently reads:
In the outpatient population, Chokshi et al. reported that a higher co-morbidity index was associated with a lower chance of receiving a statin [15]. This is in line with the findings of Noaman et al., who reported that a higher comorbidity index increased the likelihood of receiving a statin [26]. In contrast, Gnjidic et al. found that those with a higher co-morbidity index were more likely to receive a statin in a nursing home population [14]. Further, Tija et al. studied the advanced dementia population living in a nursing home and reported that statin use was more likely in patients with comorbidities such as hypertension, diabetes mellitus, or stroke [24]. These findings suggest that the presence of multiple co-morbidities decreases the likelihood of receiving a statin in the community but increases the likelihood in persons living in nursing homes. One explanation for the discrepancy is that in the Gnjidic et al. study, 94% of statin users were receiving statins for secondary prevention at baseline [14]. Thus, even with more co-morbidities, the validity of statin use may be perceived to be greater and people would be kept on statins.
It should read:
In the outpatient population, Chokshi et al. reported that a higher co-morbidity index was associated with a lower chance of receiving a statin [15], while Noaman et al. reported that a higher co-morbidity index increased likelihood of receiving a statin on hospital admission [26]. Gnjidic et al. found that those with a higher co-morbidity index were more likely to receive a statin in a nursing home population [14]. Furthermore, Tija et al. studied the advanced dementia population living in a nursing home and reported that statin use was more likely in patients with co-morbidities such as hypertension, diabetes, or stroke [24]. These findings suggest conflicting evidence for the effect of co-morbidities on statin use in the community, while increasing co-morbidity appears to raise the likelihood of receiving a statin for persons living in nursing homes. One explanation is that in the Gnjidic et al. study, 94% of statin users were receiving statins for secondary prevention at baseline [14]. Thus, even with more co-morbidities, the validity of statin use may be perceived to be greater and people would be kept on statins.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thompson, W., Pottegård, A., Nielsen, J.B. et al. Correction to: How Common is Statin Use in the Oldest Old?. Drugs Aging 35, 1025 (2018). https://doi.org/10.1007/s40266-018-0595-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-018-0595-6